Old Web
English
Sign In
Acemap
>
authorDetail
>
Danae E. Poer DeRaad
Danae E. Poer DeRaad
Biology
Antibody
Epitope
Virology
Neutralizing antibody
2
Papers
22
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults
2019
Vaccine
Christopher W. Woods
Ana M. Sanchez
Geeta K. Swamy
Micah T. McClain
Lynn Harrington
D. Freeman
Elizabeth A. Poore
Dawn K. Slifka
Danae E. Poer DeRaad
Ian J. Amanna
Mark K. Slifka
Shu Cai
Venus Shahamatdar
Michael R. Wierzbicki
Cyrille Amegashie
Emmanuel B. Walter
Show All
Source
Cite
Save
Citations (13)
Advanced oxidation technology for the development of a next-generation inactivated West Nile virus vaccine
2018
Vaccine
Benjamin K. Quintel
Archana Thomas
Danae E. Poer DeRaad
Mark K. Slifka
Ian J. Amanna
Show All
Source
Cite
Save
Citations (9)
1